(Q34720527)

4 August 2017

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women (English)

1 reference

4 August 2017

1 reference

William David Foulkes

object named as

William D Foulkes

1

0 references

Steven A. Narod

16

object named as

Steven A Narod

1 reference

4 August 2017

14

Marc Tischkowitz

1 reference

4 August 2017

Parviz Ghadirian

2

1 reference

4 August 2017

Mohammed Reza Akbari

3

1 reference

4 August 2017

Nancy Hamel

4

1 reference

4 August 2017

Sylvie Giroux

5

1 reference

4 August 2017

Nelly Sabbaghian

6

1 reference

4 August 2017

Andrew Darnel

7

1 reference

4 August 2017

Robert Royer

8

1 reference

4 August 2017

Aletta Poll

9

1 reference

4 August 2017

Eve Fafard

10

1 reference

4 August 2017

André Robidoux

11

1 reference

4 August 2017

Ginette Martin

12

1 reference

4 August 2017

Tarek A Bismar

13

1 reference

4 August 2017

Francois Rousseau

15

1 reference

4 August 2017

1 January 2007

1 reference

4 August 2017

Breast Cancer Research

1 reference

4 August 2017

9

1 reference

4 August 2017

R83

1 reference

4 August 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1186/bcr1828

4 August 2017

0 references

cites work

Analysis of PALB2/FANCN-associated breast cancer families

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Fanconi anemia is associated with a defect in the BRCA2 partner PALB2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Evaluation of BRCA1 and BRCA2 mutation prevalence, risk prediction models and a multistep testing approach in French-Canadian families with high risk of breast and ovarian cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

BRCA1 and BRCA2: 1994 and beyond

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Tracing the network connecting BRCA and Fanconi anaemia proteins

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Biallelic inactivation of BRCA2 in Fanconi anemia

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Population genetics of BRCA1 and BRCA2.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

Identification of the breast cancer susceptibility gene BRCA2

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2246183

A recurrent mutation in PALB2 in Finnish cancer families.

7 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR1828

Significant proportion of breast and/or ovarian cancer families of French Canadian descent harbor 1 of 5BRCA1 andBRCA2 mutations

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FBCR1828

Assessment of the prevalence of the 985A>G MCAD mutation in the French-Canadian population using allele-specific PCR

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18053174

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/BCR1828

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference